Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Unknown 7Completed 5Recruiting 4Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Head & Neck 4Endocrine 4

Conditions

Breast Neoplasms 1324Neoplasms 982Carcinoma, Non-Small-Cell Lung 860Prostatic Neoplasms 724Colorectal Neoplasms 666Lung Neoplasms 551Leukemia, Myeloid, Acute 475Neoplasm Metastasis 434Pancreatic Neoplasms 419Carcinoma, Hepatocellular 407Multiple Myeloma 396Ovarian Neoplasms 392Stomach Neoplasms 379Recurrence 364Squamous Cell Carcinoma of Head and Neck 325Melanoma 294Brain Neoplasms 287Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 271Glioblastoma 264Head and Neck Neoplasms 263Precursor Cell Lymphoblastic Leukemia-Lymphoma 254Endometrial Neoplasms 234Lymphoma 228Rectal Neoplasms 222Esophageal Neoplasms 222Sarcoma 213Carcinoma, Renal Cell 203Colonic Neoplasms 194Lymphoma, Non-Hodgkin 191

Interventions

surufatinib 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Interventional × Differentiated Thyroid Cancer × Clear all
NCT05852223 2026-04-20

NePenThe

Istituti Clinici Scientifici Maugeri SpA

Phase 2 Recruiting
25 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05604963 2026-03-05

HoT

University College, London

Phase NA Recruiting
456 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05599139 2026-02-06

IULID

University Medical Center Groningen

Phase NA Recruiting
25 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT05989425 2023-08-14

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Fudan University

Phase 2 Recruiting
32 enrolled
EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡